Prepare of Avastin-chitosetn nanoparticles

ZHOU Nan,HUANG Xiao,LI Yu-Zhen,CHENG Jin-Wei,CAI Ji-Ping
DOI: https://doi.org/10.13389/j.cnki.rao.2012.02.033
2012-01-01
Abstract:Objective To choose chitosan as the drug carrier and to prepare the Avastin-chitosan nanoparticles(Avastin-CS-NP) with extraorgan release.Methods The Avastin-CS-NP was prepared according to the ionotropic gelation.The size and distribution of nanoparticles(NP) were measured using the Malvern laser master-sizer and the morphology of NP was observed by transmission electron microscope(TEM).The encapsulation rate and loading concentration of nanoparticles were measured by means of Micro-BCA.The release curve in vitro of Avastin-CS-NP as observed and its stability was observed.Results The morphology of Abastin-CS-NP was round or near round,and the size was regular.Particle size spread narrow and the average diameter was 88.9 nm.The encapsulation efficiency and loading concentration of Avastin-CS-NP were 83.4% and 10.4%,respectively.In vitro release studies showed that the drug release from chitosan based nanoparticle systems was typified by a 25.70% initial rapid release(burst effect) within the first 8 hours followed by a steady release as 80% to 90% extended for 96 hours.Conclusion The nanoparticles possess good physical performance and sustained release character in vitro.
What problem does this paper attempt to address?